Publications in Refereed Journals
  1. Nalesnik MA, Myerowitz RL, Jenkins R, Lenkey J, Herbert D: Significance of Aspergillus species isolated from respiratory tract secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Micro 11:370-376, 1980.
  2. Nalesnik MA, Martinez AJ, Heros RC: Intracranial lipoma with hematopoietic elements (myelolipoma). Report of a case with successful surgical resection. Cancer 50:295-299, 1982.
  3. Nalesnik MA, Frisch C, Whiteside T: Instrument features comparison chart: Immunonephelometers. J Clin Lab Automat 2:218-219, 1982.
  4. Singh G, Thompson M, Griffith B, Bernstein RL, Rabin BS, Hardesty R, Nalesnik MA, Bahnson H: Histocompatibility in cardiac transplantation with particular reference to immunopathology of positive serologic crossmatch. Clin Immunol Immunopath 28:56-66, 1983.
  5. Nalesnik MA, Rabin BS: A comparison of direct immunofluorescence and the avidin-biotin-peroxidase conjugate technique (ABC) in the performance of the antinuclear antibody test. Am J Clin Path 81:192-197, 1984.
  6. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW, Hardesty RL, Atchison RW, Jaffe R, Bahnson HT: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1:583-587, 1984.
  7. Demetris AJ, Nalesnik MA, Kunz HW, Gill TJ, Shinozuka H: Sequential analyses of the development of lymphoproliferative disorders in rats receiving cyclosporine. Transplantation 38:239-246, 1984.
  8. Starzl TE, Iwatsuki S, Shaw BW, Greene DA, Van Thiel D, Nalesnik MA, Nusbacher J, Hakala TR: Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet 159:265-272, 1984.
  9. Johnson JT, Oral A, Nalesnik MA, Roscoe GJ, Whiteside TL: Giant lymph node hyperplasia: Clinical and immunohistochemical correlation of an intermediate variant. Ear Nose Throat J 64:249-254, 1985.
  10. Starzl TE, Iwatsuki S, Shaw BW, Nalesnik MA, Farhi DC, Van Thiel DT: Treatment of fibrolamellar hepatoma with partial hepatectomy or with total hepatectomy and liver transplantation. Surg Gynecol Obstet , 1985.
  11. Berman MA, Nalesnik MA, Kapadia SB, Rinaldo CR, Jensen F: Primary lymphadenopathic Kaposi’s sarcoma in an immunocompetent 23 year old man. Am J Clin Path 86:366-369, 1986.
  12. Mittal BB and Nalesnik MA: Composite lymphoma (Hodgkin’s and non-Hodgkin’s) of the spleen in a previously untreated patient. Acta Haemat (Basel) 76:29-32, 1986.
  13. Nalesnik MA, Starzl TE, Porter KA, Sklar J, Clearly ML: Genotypic analysis of Cyclosporine-associated lymphoproliferations. Transplantation 43:592-593, 1987.
  14. Harris KM, Schwartz ML, Slasky BS, Nalesnik MA, Makowka L: Post-transplantation cyclosporine-induced lymphoproliferative disorders: Clinical and radiologic manifestations. Radiology 162:697-700, 1987.
  15. Makowka L and Nalesnik MA: Management of post-transplant lymphoproliferative disorders by reduction of immunosuppression. Immunopath Immunother Lett 3(1): 1987.
  16. Nalesnik MA, Makowka L and Starzl TE: The diagnosis and treatment of post-transplant lymphoproliferative disorders. Curr Prob Surg 25(6):367-472, 1988.
  17. Nalesnik MA, Jaffe R, Porter KA, Stieber A, Makowka L, Ho M, Atchison RW, Lee RE and Starzl TE: The pathology of post-transplant lymphoproliferative disorders occurring in the setting of Cyclosporine A-Prednisone immunosuppression. Am J Pathol 133(1):173-192, 1988.
  18. Ho M, Jaffe R, Miller G, Breinin MK, Dummer JS, Makowka L, Atchison RW, Karrer F, Nalesnik MA and Starzl TE: The frequency of EBV infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45(4):719-727, 1988.
  19. Gryzan S, Paradis IL, Zeevi A, Duquesnoy RJ, Dummer JS, Griffith BP, Hardesty RL, Trento A, Nalesnik MA and Dauber JH: Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation: Implications for lung defense and allograft survival. Am Rev Resp Dis 137:1268-1274, 1988.
  20. Todo S, Ueda Y, Demetris AJ, Imventarza O, Nalesnik M, Venkataramanan R, Makowka L and Starzl TE: Immunosuppression of canine, monkey, and baboon allografts by FK506: With special reference to synergism with other drugs, and to tolerance induction. Surgery 104(2):239-249, 1988.
  21. Cleary ML, Nalesnik MA, Shearer WT and Sklar J: Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72(1):349-352, 1988.
  22. Yousem SA, Randhawa P, Locker J, Paradis IL, Dauber JA, Griffith BP, Nalesnik MA: Post-transplant lymphoproliferative disorders in heart-lung transplant recipients: Primary presentation in the allograft. Human Pathol 20:361-369, 1989.
  23. Locker J and Nalesnik M: Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135(6):977-987, 1989.
  24. al-Sabbagh MR, Steen VD, Zee BC, Nalesnik M et al: Pulmonary arterial histology and morpholometry in systemic sclerosis: A case control autopsy study. J Rheumatol 16(8):1038-1042, 1989.
  25. Nalesnik MA: Involvement of the gastrointestinal tract by Epstein-Barr virus-associated lymphoproliferative disorders. Am J Surg Pathol 14(1):92-100, 1990.
  26. Liu T, Walsh TR, Nalesnik M and Makowka L: Improved preservation of the rat liver for orthotopic liver transplantation: Use of University of Wisconsin lactobionate solution and retrograde reflushing. Surgery 108(5):890-897, 1990.
  27. Hickey DP, Nalesnik MA, Vivas CA, Lopatin WB, Jordan ML, Starzl TE, Hakala TR: Renal re-transplantation in patients who lost their allografts during management of previous post-transplant lymphoproliferate diseases. Clin Transplant 4:187, 1990.
  28. Murase N, Lieberman L, Nalesnik MA, Mintz D, Todo S, Drash AL, Starzl TE: Rapid Communication: The effect of FK506 on spontaneous diabetes in the BB rat. Diabetes 39(12):1584-1586, 1990.
  29. Murase N, Lieberman I, Nalesnik M, Mintz D, Todo S, Drash AL, Starzl TE: Prevention of spontaneous diabetes in BB rats with FK506 (letter). Lancet 336(8711):373-374, 1990.
  30. Lopatin WB, Hickey DP, Nalesnik MA et al: Post-transplant lymphoproliferative disease and triple therapy. Clin Transplant 4:47, 1990.
  31. Spencer E and Nalesnik MA: Having problems with frozen sections? Instrumentation Laboratory: Histology Technical Bulletin (1):8, 1990.
  32. Wren SM, Nalesnik MA, Hronakes ML, Ildstad ST: Mixed chimerism to induce tolerance for solid organ transplantation. J Ped Surg 26(4):439-443, 1991.
  33. Sakr MR, Zetti GM, Hassanein TI, Farghali H, Nalesnik MA, Gavaler JS, Starzl TE, Van Thiel DH: FK506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology 13(5):947-951, 1991.
  34. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS: Post-transplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporin based immunosuppression. Am J Heart Lung Transplant 10(6):877-886, 1991.
  35. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik MA, Chen Y-Y and Weiss LM: The systemic distribution of Epstein-Barr virus genomes in fatal post-transplant lymphoproliferative disorders: An in-situ hybridization study. Am J Path 138(4):1027-1033, 1991.
  36. Nalesnik MA: Concepts in Immunopathology: Lymphoproliferative disease in a transplant population. Springer Semin Immunopathol 13:199-216, 1991.
  37. Merkel IS, Good CB, Nalesnik M and Roseman SR: Chronic Pneumocystis carinii infection of the liver: A case report and review of the literature. J Clin Gastroenterol 15(1):55-58,1992.
  38. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM: Expression of Epstein-Barr virus-associated small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 327:1710-1714, 1992.
  39. Sakr M, Zetti G, McClain C, Gavaler J, Nalesnik M, Todo S, Starzl T, Van Thiel D: The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rat. Transplantation 53(5):987-991, 1992.
  40. Nalesnik MA, Locker J, Jaffe R, Reyes J, Cooper M, Fung J, Starzl TE: Experience with post-transplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplantation (Special issue) 6:249-252, 1992.
  41. Mueller AR, Nalesnik MA, Langrehr JM, Rao PN, Snyder JT, Hoffman RA, Schraut WH: Evidence that small bowel preservation causes primarily basement membrane and endothelial rather than epithelial cell injury. Transplantation 56:1499-1504, 1993.
  42. Lemster B, Rilo HR, Carroll PB, Nalesnik MA, Thomson AW: FK506 inhibits cytokine gene and adhesion molecule expresison in psoriatic skin lesions. Ann NY Acad Sci 696:250-256, 1993.
  43. Tamura K, Woo J, Nalesnik M, Thomson AW: Inhibitory effect of FK506 n autoimmune thyroid disease in the PVG rat. Ann NY Acad Sci 696:257-262, 1993.
  44. Cooper MH, Nalesnik MA, Watkins SC, Hoffman RA, Ildstad ST: Cross species graft-versus-host disease is accompanied by a donor-derived cellular immune response. Transplantation 56:934-940, 1993.
  45. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, Todo S, Tzakis A, Fung JJ, Nalesnik M, Zeevi A, Rudert WA, Kocova M: Cell migration and chimerism after whole organ transplantation: The basis of graft acceptance. Hepatology 17(6):1127-1152, 1993.
  46. Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J: Lymphoma resembling Hodgkin disease after post-transplant lymphoproliferative disorder (PTLD) in a liver transplant recipient. Cancer 72(9):2568-2573, 1993.
  47. Tamura K, Woo J, Murase N, Carrieri G, Nalesnik MA, Thomson AW: Suppression of autoimmune thyroid disease by FK506: Influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production. Clin Exp Immunol 91(3):368-375, 1993.
  48. Wennerberg A, Nalesnik MA: Hepatocyte-specific antigen. A marker of hepatocyte differentiation applicable to routinely processed tissues. Am J Pathol 143(4):1050-1054, 1993.
  49. Yamaguchi K, Nalesnik MA and Carr BI: In situ hybridization of albumin mRNA in normal liver and liver tumors: Identification of hepatocullarl origin. Virchows Archiv B Cell Pathol 64:361-365, 1993.
  50. Muller AR, Langrehr JM, Nalesnik M, Hoffman RA, Lee TK, Lee KKW, Schraut WH: Mucosal glutaminase activity and histology as parameters of small bowel preservation injury. J of Surg Res 56(3):207-215, 1994.
  51. Muller AR, Nalesnik M, Platz KP, Langrehr JM, Hoffman RA, Schraut WH: Evaluation of preservation conditions and various solutions for small bowel preservation. Transplanation 57:649-655, 1994.
  52. Randhawa PS, Zeevi A, Alvares C, Gollin S, Agostini R, Yunis E, Saidman S, Contis L, Demetris AJ, Nalesnik MA: Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease. In Vitro Cellular & Develop Biol. Animal. 30A:400-406, 1994.
  53. Mueller AR, Platz KP, Langrehr JM, Hoffman RA, Nussler AK, Nalesnik M, Billiar TR, Schraut WH: The effects of administration of nitric oxide inhibitors during small bowel preservation and reperfusion. Transplantation 58: 1309-1316, 1994.
  54. Yamaguchi K, Carr BI, Nalesnik MA: Concomitant and isolated expression of TGF-alpha and ECG-R in human hepatoma cells support autocrine and/or paracrine growth of human hepatoma. J Surg Oncol, 58:240-245, 1995.
  55. Thomson AW, Nalesnik MA, Rilo HR, Woo J, Carroll PB, Van Theil DH: ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK506 therapy. Autoimmunity 15:215-223, 1995.
  56. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS: The association of Epstein-Barr Virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332:19-25, 1995.
  57. Randhawa P, Starzl TE, Ramos HC, Nalesnik MA, Demetris AJ: Allografts surviving for 26 to 29 years following living related kidney transplantation: Analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies. Am J Kid Dis, 24:72-7, 1994.
  58. Nalesnik MA and Starzl TE: Epstein-Barr Virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Science 4:61-79, 1994.
  59. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ and Lotze MT: Recombinant IL-12 administration induces tumor regression in association with IFN-g production. J Immunol 153:1697-1706, 1994.
  60. Randhawa PS, Demetris AJ and Nalesnik MA: The potential role of cytokines in the pathogenesis of Epstein-Barr Virus associated post-transplant lymphoproliferative disease. Leukemia and Lymphoma 15:383-397, 1994.
  61. Kocova M, Siegel SF, Nalesnik M, Trucco M: Detection of Y-chromosome sequences in gonadal tissue of patients with Turner's syndrome (45,X) [letter] N Engl J Med 331:682-3, 1994.
  62. Randhawa PS, Demetris J, Nalesnik MA: EBER gene expression in Epstein-barr virus-associated hematopoietic neoplasms. Leuk Lymphoma 13:387-92, 1994.
  63. Ricordi C, Tzakis, AG, Zeevi A, Rybka WB, Demetris AJ, Fontes PA, Nalesnik MA, Trucco M, Ukah FO, Ball ED, et al. Reversal of graft- versus-host disease with infusion of autologous bone marrow. Cell Transplantation 3:187-192, 1994.
  64. Muller AR, Nalesnik M, Platz KP, Langrehr JM, Hoffman RA, Schraut WH: Evaluation of preservation conditions and various solutions for small bowel preservation. Transplantation 57:649-55, 1994.
  65. Randhawa P, Nalesnik M, Demetris J, Zeevi A: Interleukin-10 production by a B-cell line derived from human post-transplant lymphoproliferative disease. Heamtol Oncol 13:13-18, 1995.
  66. Kocova M, Siegel SF, Wenger SL, Lee PA, Nalesnik M, Trucco M: Detection of Y chromosome sequences in a 45,X/46,XXq--patient by Southern blot analysis of PCR-amplified DNA and fluorescent in situ hybridization. Am J of Med Genet 55:483-488, 1995.
  67. Randhawa P, Demetris AJ, Nalesnik MA: Epstein-Barr virus-encoded RNA expression as a risk factor for the development of posttransplantation lymphoproliferative disease. Hepatology 21:1752-1754, 1995.
  68. Madariaga JR, Nalesnik MA, Todo S, Iwatsuki S, Starzl TE: Spindle cell tumor of the portal vein: A case report.J of Surg Oncol 59:139-141, 1995.
  69. Colson YL, Zadach K, Nalesnik M and Ildstad ST: Mixed allogeneic chimerism in the rat: Donor specific transplantation tolerance and prevention of chronic rejection for primarily vascularized cardiac allografts. Transplantation 60:971-980, 1995.
  70. Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT: Cancer immunotherapy of established tumors with IL-12. Effective delivery by genertically engineered fibroblasts. J Immunol 155:1393-1403, 1995.
  71. Aguilera NS, Kapadia SB, Nalesnik MA and Swerdlow SH: Extramedullary plasmacytoma of the head and neck: Use of paraffin sections to assess clonality with in situ huybridization, growth fraction and the presence of epstein-barr virus. Modern Pathology 8:503-508, 1995.
  72. Woo J, Wright TM, Lemster B, Borochovitz D, Nalesnik MA and Thomson AW: Combined effects of FK506 (Tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MLR-Ipr/Ipr mice. Clin Exp Immunol 100:118-125, 1995.
  73. Tsamandas AC, Jain AB, Raikow RB, Demetris AJ, Nalesnik MA, Randhawa PS: Extramedullary hematopoiesis in the allograft liver. Modern Pathol 8:671-674, 1995.
  74. Yamaguchi K, Michalopoulos G, Nalesnik MA: Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization. Urological Research, In press, 1996.
  75. Yamaguchi K, Nalesnik MA, Michalopoulos GK: HGF mRNA in human liver cirrhosis as evidenced by in situ hybridization. Scand J of Gastroenterol, In press, 1996.